Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1963 Jan 1;117(1):105–125. doi: 10.1084/jem.117.1.105

THE EFFECT OF RHEUMATOID FACTORS AND OF ANTIGLOBULINS ON IMMUNE HEMOLYSIS IN VIVO

Manuel E Kaplan 1, James H Jandl 1
PMCID: PMC2180434  PMID: 14030746

Abstract

Studies were undertaken in man and in the rat comparing the effects of rheumatoid factors and immune antiglobulins on red cells sensitized with incomplete antibodies. The interaction of immune antiglobulins with sensitized red cells produced (a) agglutination in vitro and (b) an accelerated sequestration of the sensitized cells in vivo. In contrast, rheumatoid macroglobulins, although capable of agglutinating Rh-sensitized red cells in vitro, did not modify their destruction in vivo. The failure of rheumatoid factors to function as antiglobulins in vivo appears to reflect their non-reactivity with sensitized cells in whole serum. It is suggested: (a) that the native (7S) gamma globulins of plasma competitively inhibit rheumatoid factors from reacting with fixed antibody in the blood stream; (b) that if these macroglobulins do indeed have pathogenetic activity, this may be limited to body fluids of low protein content.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHRISTIAN C. L. Characterization of the reactant (gamma globulin factor) in the F II precipitin reaction and the F II tanned sheep cell agglutination test. J Exp Med. 1958 Jul 1;108(1):139–157. doi: 10.1084/jem.108.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. EDELMAN G. M., KUNKEL H. G., FRANKLIN E. C. Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J Exp Med. 1958 Jul 1;108(1):105–120. doi: 10.1084/jem.108.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EMERSON C. P., FRANKLIN W., LOWELL F. C. The production of potent antihuman globulin (Coombs reagent) in rabbits immunized with serum adjuvant mixtures. J Immunol. 1951 Mar;66(3):323–328. [PubMed] [Google Scholar]
  4. EPSTEIN W., JOHNSON A., RAGAN C. Observations on a precipitin reaction between serum of patients with rheumatoid arthritis and a preparation (Cohn fraction II) of human gamma globulin. Proc Soc Exp Biol Med. 1956 Feb;91(2):235–237. doi: 10.3181/00379727-91-22223. [DOI] [PubMed] [Google Scholar]
  5. FRANKLIN E. C., HOLMAN H. R., MULLER-EBERHARD H. J., KUNKEL H. G. An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med. 1957 May 1;105(5):425–438. doi: 10.1084/jem.105.5.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FRANKLIN E. C., KUNKEL H. G., MULLER-EBERHARD H. J., HOLMAN H. R. Relation of high molecular weight proteins to the serological reactions in rheumatoid arthritis. Ann Rheum Dis. 1957 Sep;16(3):315–321. doi: 10.1136/ard.16.3.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FUDENBERG H. H., KUNKEL H. G. Specificity of the reaction between rheumatoid factors and gamma globulin. J Exp Med. 1961 Aug 1;114:257–278. doi: 10.1084/jem.114.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRUBB R. Interactions between rheumatoid arthritic sera and human gammaglobulin. Acta Haematol. 1958 Jul-Oct;20(1-4):246–252. doi: 10.1159/000205490. [DOI] [PubMed] [Google Scholar]
  9. GRUBB R., LAURELL A. B. Hereditary serological human serum groups. Acta Pathol Microbiol Scand. 1956;39(6):390–398. doi: 10.1111/j.1699-0463.1956.tb05067.x. [DOI] [PubMed] [Google Scholar]
  10. GRUBB R. The Gm groups and their relation to rheumatoid arthritis serology. Arthritis Rheum. 1961 Apr;4:195–202. doi: 10.1002/art.1780040209. [DOI] [PubMed] [Google Scholar]
  11. JACOB H. S., JANDL J. H. Effects of sulfhydryl inhibition on red blood cells. I. Mechanism of hemolysis. J Clin Invest. 1962 Apr;41:779–792. doi: 10.1172/JCI104536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. JACOB H. S., JANDL J. H. Effects of sulfhydryl inhibition on red blood cells. II. Studies in vivo. J Clin Invest. 1962 Jul;41:1514–1523. doi: 10.1172/JCI104607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JANDL J. H., JONES A. R., CASTLE W. B. The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest. 1957 Oct;36(10):1428–1459. doi: 10.1172/JCI103542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. JANDL J. H., KAPLAN M. E. The destruction of red cells by antibodies in man. III. Quantitative factors influencing the patterns of hemolysis in vivo. J Clin Invest. 1960 Jul;39:1145–1156. doi: 10.1172/JCI104129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. JANDL J. H., KATZ J. H. The plasma-to-cell cycle of transferrin in iron utilization. Trans Assoc Am Physicians. 1961;74:72–76. [PubMed] [Google Scholar]
  16. JANDL J. H., SIMMONS R. L. The agglutination and sensitization of red cells by metallic cations: interactions between multivalent metals and the red-cell membrane. Br J Haematol. 1957 Jan;3(1):19–38. doi: 10.1111/j.1365-2141.1957.tb05768.x. [DOI] [PubMed] [Google Scholar]
  17. KAPLAN M. E., JANDL J. H. Inhibition of red cell sequestration by cortisone. J Exp Med. 1961 Dec 1;114:921–937. doi: 10.1084/jem.114.6.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KUNKEL H. G. Significance of the rheumatoid factor. Arthritis Rheum. 1958 Aug;1(4):381–383. doi: 10.1002/art.1780010410. [DOI] [PubMed] [Google Scholar]
  19. LAURELL C. B., NYMAN M. Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. Blood. 1957 Jun;12(6):493–506. [PubMed] [Google Scholar]
  20. MASOUREDIS S. P. Reaction of I-131 trace labeled human anti-Rho(D) with red cells. J Clin Invest. 1959 Feb;38(2):279–290. doi: 10.1172/JCI103800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. PARKER R. L., SCHMID F. R. Phagocytosis of particulate complexes of gamma-globulin and rheumatoid factor. J Immunol. 1962 Apr;88:519–525. [PubMed] [Google Scholar]
  22. SWAHN B., GRUBB R. Purification of hemagglutinating factors in rheumatoid arthritic sera by Cohn's method 10 and ultracentrifugation. Acta Pathol Microbiol Scand. 1958;42(2):173–180. doi: 10.1111/j.1699-0463.1958.tb03182.x. [DOI] [PubMed] [Google Scholar]
  23. VAUGHAN J. H., BUTLER V. P., Jr Current status of the rheumatoid factor. Ann Intern Med. 1962 Jan;56:1–11. doi: 10.7326/0003-4819-56-1-1. [DOI] [PubMed] [Google Scholar]
  24. VAUGHAN J. H., ELLIS P. J., MARSHALL H. Quantitative considerations of the rheumatoid factor. J Immunol. 1958 Sep;81(3):261–269. [PubMed] [Google Scholar]
  25. WALLER M. V., VAUGHAN J. H. Use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis. Proc Soc Exp Biol Med. 1956 May;92(1):198–200. doi: 10.3181/00379727-92-22426. [DOI] [PubMed] [Google Scholar]
  26. ZIFF M. The agglutination reaction in rheumatoid arthritis. J Chronic Dis. 1957 Jun;5(6):644–667. doi: 10.1016/0021-9681(57)90074-7. [DOI] [PubMed] [Google Scholar]
  27. van LOGHEM J. J., KRESNER M. Observations on a prozone phenomenon encountered in using the anti-globulin sensitisation test. Lancet. 1950 Dec 9;2(6641):729–732. doi: 10.1016/s0140-6736(50)91672-2. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES